Stay updated on Pembrolizumab and CMP-001 in Operable Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab and CMP-001 in Operable Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab and CMP-001 in Operable Melanoma Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedThe study history now includes a new version entry for 2026-09-21 introducing Conditions and Study Status with Revision: v3.7.0, and the prior revision reference v3.6.6 dated 2026-08-04 was removed.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedThe page now displays Revision: v3.6.6, replacing the previous v3.6.5. This indicates a small update to the page's revision metadata.SummaryDifference0.0%

- Check56 days agoChange DetectedThe study history was updated to add a new revision (v3.6.5) on 2026-08-04, introducing the Study Status and Contacts/Locations sections, and the prior revision (v3.6.4) from 2026-07-31 was removed.SummaryDifference0.1%

- Check63 days agoChange DetectedThe record history now includes a new revision on 2026-07-31 that adds the Contacts/Locations and Study Status sections (associated with version 211), following an earlier 2026-07-30 entry. A deletion dated 2026-05-14 is also reflected in the history.SummaryDifference0.1%

- Check70 days agoChange DetectedA new page revision entry, v3.6.4, was added to the history. The previous revision, v3.6.3, was removed.SummaryDifference0.0%

- Check92 days agoChange DetectedThe history now includes a new Revision: v3.6.3 entry, updating the page to the latest revision and replacing the previous v3.6.2 entry.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab and CMP-001 in Operable Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab and CMP-001 in Operable Melanoma Clinical Trial page.